Bone Marrow Transplant and GVHD
Assessment
Multiple systems are at risk for late effects after bone marrow transplant. Survivors should be carefully monitored for late effects.
Screening and prevention guidelines for BMT survivors have been developed by a consensus panel consisting of members of the Center for International Blood and Marrow Transplant Research (CIBMTR), European Group for Blood and Marrow Transplantation (EBMT), and American Society for Bone Marrow Transplantation.
A thorough history and physical examination (including height, weight and blood pressure) should be performed on at least an annual basis. The following table gives an overview of the most important long term health risks to assess and monitor in long-term follow up after BMT:
Organ System |
History: Ask about |
Investigation |
Kidney |
|
MEASURE BLOOD PRESSURE Hypertension is common in this group of patients as a late effect |
Renal function tests:
|
||
Thyroid |
|
Check thyroid function tests:
|
|
Examine thyroid every year
Ultrasound scan of thyroid every 3 years
|
|
|
|
Measure BMI and BP |
Gonadal dysfunction | Hypogonadism: Examples of relevant questions:
|
Measure gonadal and pituitary hormone levels |
Infertility:
|
Referral to fertility specialist | |
CNS |
|
Neurological examination of higher mental status
May need referral to psychologist for:
|
|
MR of brain every 3 years to exclude RT induced meningioma | |
Psychological |
|
May need referral to counseling and psychiatry |
|
Examination of skin for: cGvHD:
Skin cancers:
|
|
|
Examination of mouth, teeth and oral cavity for:
|
|
|
Examination for:
|
|
|
Examination for:
|
|
Blood work:
|
||
|
||
Hepatic |
|
Examination of liver
Blood work:
|
|
Examination of chest:
CXR Chest CT Pulmonary function tests |
|
|
Examination of joints:
Assessment of bone density
|
|
Hematopoietic |
|
Examination of skin:
Measure:
|
|
Bone marrow biopsy to exclude treatment related leukemia | |
Immune System |
|
Thyroid cancer and RT induced meningiomas as second malignancies are not uncommon, but have very slow natural histories. Other malignant second neoplasms are unlikely to have such indolent courses, or to be picked up by screening. Patients should know to seek immediate advice should they develop new symptoms such as pain, swelling or headache.